Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric van Exel

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Frontiers in Psychiatry|August 1, 2022
Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methodsMarieke J Henstra, Thomas C Feenstra, Rob M Kok, et al.
The American Journal of Psychiatry|March 11, 2026
A Global Delphi-Based Expert Consensus on Relapse Prevention Strategies Following Successful Electroconvulsive Therapy for Major Depressive DisorderJordy J E Rovers, Philip F P van Eijndhoven, Christopher Abbot, et al.
Schizophrenia Bulletin|October 8, 2021
Neural Substrates of Psychotic Depression: Findings From the Global ECT-MRI Research CollaborationAkihiro Takamiya, Annemiek Dols, Louise Emsell, et al.
The American Journal of Psychiatry|March 19, 2025
Assessment and Management of Concurrent Substance Use in Patients Receiving Repetitive Transcranial Magnetic Stimulation for Depressive, Obsessive-Compulsive, Psychotic, and Trauma-Related Disorders: A Delphi Consensus Study and GuidelineVictor M Tang, Scott Aaronson, Mohamed Abdelghani, et al.
Journal of Psychiatry & Neuroscience : JPN|July 5, 2021
Elevated body weight modulates subcortical volume change and associated clinical response following electroconvulsive therapyNils Opel, Katherine L. Narr, Christopher Abbott, et al.
Biological Psychiatry|December 27, 2021
Interrogating Associations Between Polygenic Liabilities and Electroconvulsive Therapy EffectivenessJurjen J Luykx, Dore Loef, Bochao Lin, et al.
Brain Stimulation|February 19, 2026
Vital-Affective Symptom Connectivity During Electroconvulsive Therapy Distinguishes Depression Remission Outcomes: A Cross-Lagged Panel Network StudyMelissa G Zandstra, Gabriela Lunansky, Floortje E Scheepers, et al.
Molecular Psychiatry|October 25, 2024
A prediction model for electroconvulsive therapy effectiveness in patients with major depressive disorder from the Dutch ECT Consortium (DEC)Dore Loef, Adriaan W Hoogendoorn, Metten Somers, et al.
Comprehensive Psychiatry|May 29, 2026
Effectiveness of electroconvulsive therapy for depression: comparing research studies with real-world clinical data from the Dutch ECT consortiumRobin C Cobben, Dore Loef, Edwin van Dellen, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Frontiers in Psychiatry|August 1, 2022
Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methodsMarieke J Henstra, Thomas C Feenstra, Rob M Kok, et al.
The American Journal of Psychiatry|March 11, 2026
A Global Delphi-Based Expert Consensus on Relapse Prevention Strategies Following Successful Electroconvulsive Therapy for Major Depressive DisorderJordy J E Rovers, Philip F P van Eijndhoven, Christopher Abbot, et al.
Schizophrenia Bulletin|October 8, 2021
Neural Substrates of Psychotic Depression: Findings From the Global ECT-MRI Research CollaborationAkihiro Takamiya, Annemiek Dols, Louise Emsell, et al.
The American Journal of Psychiatry|March 19, 2025
Assessment and Management of Concurrent Substance Use in Patients Receiving Repetitive Transcranial Magnetic Stimulation for Depressive, Obsessive-Compulsive, Psychotic, and Trauma-Related Disorders: A Delphi Consensus Study and GuidelineVictor M Tang, Scott Aaronson, Mohamed Abdelghani, et al.
Journal of Psychiatry & Neuroscience : JPN|July 5, 2021
Elevated body weight modulates subcortical volume change and associated clinical response following electroconvulsive therapyNils Opel, Katherine L. Narr, Christopher Abbott, et al.
Biological Psychiatry|December 27, 2021
Interrogating Associations Between Polygenic Liabilities and Electroconvulsive Therapy EffectivenessJurjen J Luykx, Dore Loef, Bochao Lin, et al.
Brain Stimulation|February 19, 2026
Vital-Affective Symptom Connectivity During Electroconvulsive Therapy Distinguishes Depression Remission Outcomes: A Cross-Lagged Panel Network StudyMelissa G Zandstra, Gabriela Lunansky, Floortje E Scheepers, et al.
Molecular Psychiatry|October 25, 2024
A prediction model for electroconvulsive therapy effectiveness in patients with major depressive disorder from the Dutch ECT Consortium (DEC)Dore Loef, Adriaan W Hoogendoorn, Metten Somers, et al.
Comprehensive Psychiatry|May 29, 2026
Effectiveness of electroconvulsive therapy for depression: comparing research studies with real-world clinical data from the Dutch ECT consortiumRobin C Cobben, Dore Loef, Edwin van Dellen, et al.
Pageof 8